Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer

NCT00662129 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: gemcitabine hydrochloride
DRUG: paclitaxel albumin-stabilized nanoparticle formulation

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]